var szzbAffiches=[["01358","finalpage/2018-08-06/1205261126.PDF","普华和顺：二零一八年第二季度及上半年CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.之未经审核业绩","PDF","251","2018-08-06","2018-08-06 08:02"],["00337","finalpage/2018-08-06/1205261125.PDF","绿地香港：股东特别大会适用的代表委任表格","PDF","324","2018-08-06","2018-08-06 07:59"],["00891","finalpage/2018-08-06/1205261123.PDF","利邦：董事名单与其角色及职能","PDF","196","2018-08-06","2018-08-06 07:59"],["00005","finalpage/2018-08-06/1205261124.PDF","汇丰控股：本身股份之交易","PDF","301","2018-08-06","2018-08-06 07:59"],["00337","finalpage/2018-08-06/1205261122.PDF","绿地香港：股东特别大会通告","PDF","117","2018-08-06","2018-08-06 07:58"],["00337","finalpage/2018-08-06/1205261121.PDF","绿地香港：关连交易","PDF","1342","2018-08-06","2018-08-06 07:52"],["00377","finalpage/2018-08-06/1205261120.PDF","华君国际集团：有关收购营口目标土地之土地使用权之须予披露交易","PDF","245","2018-08-06","2018-08-06 07:52"],["01760","finalpage/2018-08-06/1205261061.PDF","英恒科技：稳定价格行动及稳定价格期结束","PDF","215","2018-08-06","2018-08-06 07:48"],["01826","finalpage/2018-08-06/1205261057.PDF","达飞控股：关连交易收购一间中国公司的51%股权","PDF","329","2018-08-06","2018-08-06 07:41"],["02005","finalpage/2018-08-06/1205260813.PDF","石四药集团：正面盈利预告","PDF","250","2018-08-06","2018-08-06 07:05"],["01715","finalpage/2018-08-06/1205260812.PDF","米技国际控股：稳定价格期结束、稳定价格行动及超额配股权失效","PDF","496","2018-08-06","2018-08-06 06:40"],["02014","finalpage/2018-08-06/1205260811.PDF","浩泽净水：自愿性公告 - 有关潜在业务合作之谅解备忘录","PDF","311","2018-08-06","2018-08-06 06:19"]];
